| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11010-010-0500-Z |
| P698 | PubMed publication ID | 20512612 |
| P50 | author | Harlokesh Narayan Yadav | Q83042128 |
| P2093 | author name string | Manjeet Singh | |
| P L Sharma | |||
| P2860 | cites work | GSK-3: tricks of the trade for a multi-tasking kinase | Q24624069 |
| Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study | Q28239287 | ||
| Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium | Q28304462 | ||
| The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms | Q28305411 | ||
| Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice | Q28369792 | ||
| Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury | Q33195698 | ||
| Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. | Q33818343 | ||
| Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore | Q34327908 | ||
| The mitochondrial death/life regulator in apoptosis and necrosis | Q34465435 | ||
| Role of bradykinin in preconditioning and protection of the ischaemic myocardium | Q34542200 | ||
| Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia | Q35044937 | ||
| The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways | Q35103813 | ||
| Protein kinase B in the diabetic heart | Q35212085 | ||
| The first minutes of reperfusion: a window of opportunity for cardioprotection | Q35666872 | ||
| Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts | Q36239622 | ||
| Preconditioning and postconditioning: united at reperfusion. | Q36903277 | ||
| Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase | Q36980730 | ||
| Ischemic preconditioning: protection against myocardial necrosis and apoptosis | Q37031353 | ||
| Role of kinins in the endothelial protective effect of ischaemic preconditioning | Q41821889 | ||
| The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study | Q41941928 | ||
| Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion | Q41977320 | ||
| Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction | Q42447096 | ||
| Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart | Q42455921 | ||
| Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels | Q42524480 | ||
| Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury | Q42615029 | ||
| Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits | Q44082810 | ||
| Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? | Q44088292 | ||
| Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. | Q44334379 | ||
| Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts | Q44344567 | ||
| Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart | Q44401253 | ||
| Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta | Q44789811 | ||
| Attenuation of antioxidative capacity enhances reperfusion injury in aged rat myocardium after MI/R. | Q45052727 | ||
| Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter | Q45064710 | ||
| Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart | Q46370395 | ||
| Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition | Q46706091 | ||
| Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. | Q46775026 | ||
| Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium | Q46804424 | ||
| The insulin sensitizer pioglitazone improves the deterioration of ischemic preconditioning in type 2 diabetes mellitus rats | Q46902898 | ||
| Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique | Q47282887 | ||
| Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect | Q47409386 | ||
| Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? | Q47612364 | ||
| Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction | Q47634971 | ||
| Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. | Q54039752 | ||
| Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor | Q56624660 | ||
| Diabetes and cardiovascular risk factors: the Framingham study | Q67462912 | ||
| Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine | Q67714898 | ||
| A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group | Q68134017 | ||
| Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischaemia | Q69994378 | ||
| Preconditioning does not prevent postischemic dysfunction in aging heart | Q71092541 | ||
| The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts | Q71214230 | ||
| Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting | Q71516815 | ||
| Differences in ischaemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats | Q72873433 | ||
| Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart | Q73573646 | ||
| Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart | Q73622609 | ||
| Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality | Q73630642 | ||
| Acute diabetes modulates response to ischemia in isolated rat heart | Q74284768 | ||
| Energy metabolism after ischemic preconditioning in streptozotocin-induced diabetic rat hearts | Q74314802 | ||
| A routine method for the estimation of lactic dehydrogenase activity | Q78795693 | ||
| Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta | Q79456093 | ||
| A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera | Q79528423 | ||
| Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty | Q81215756 | ||
| N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta | Q83150086 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 75-81 | |
| P577 | publication date | 2010-05-30 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart | |
| P478 | volume | 343 |
| Q55050291 | Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart. |
| Q94054456 | Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes |
| Q54920287 | An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning. |
| Q54243194 | Beneficial effect of zinc chloride and zinc ionophore pyrithione on attenuated cardioprotective potential of preconditioning phenomenon in STZ-induced diabetic rat heart. |
| Q49046559 | Cardioprotection by ischemic postconditioning is abolished in depressed rats: role of Akt and signal transducer and activator of transcription-3 |
| Q36407271 | Chronic Hyperinsulinemia Causes Selective Insulin Resistance and Down-regulates Uncoupling Protein 3 (UCP3) through the Activation of Sterol Regulatory Element-binding Protein (SREBP)-1 Transcription Factor in the Mouse Heart |
| Q38366174 | Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus |
| Q39151222 | Delta Opioid Receptors and Cardioprotection. |
| Q44945654 | Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β. |
| Q30457504 | Diabetic cardiomyopathy: pathophysiology and clinical features |
| Q37913053 | Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury |
| Q36651450 | Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart |
| Q36288965 | Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning |
| Q51186282 | Effects of pre-germinated brown rice treatment high-fat diet-induced metabolic syndrome in C57BL/6J mice. |
| Q28066824 | Experimental Diabetes Mellitus in Different Animal Models |
| Q64994192 | Extracellular Vesicles Derived from Hypoxic Human Mesenchymal Stem Cells Attenuate GSK3β Expression via miRNA-26a in an Ischemia-Reperfusion Injury Model. |
| Q58766782 | Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure |
| Q52675795 | Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart. |
| Q40084421 | Hydrosulfide attenuates acute myocardial ischemic injury through the glycogen synthase kinase-3β/β-catenin signaling pathway |
| Q44895018 | Identification of porcine glycogen synthase kinase 3α (GSK-3α) gene and its association with carcass traits |
| Q50049614 | Involvement of atrial natriuretic peptide in abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart |
| Q38683468 | Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus |
| Q34457775 | Ischemic conditioning: the challenge of protecting the diabetic heart |
| Q37721389 | Ischemic preconditioning: Interruption of various disorders. |
| Q55036362 | Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore. |
| Q46034115 | Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection. |
| Q84586659 | Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72 |
| Q33957346 | Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart |
| Q35014157 | Pre-germinated brown rice prevents high-fat diet induced hyperglycemia through elevated insulin secretion and glucose metabolism pathway in C57BL/6J strain mice |
| Q36274048 | Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation |
| Q41999664 | Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance |
| Q38064702 | Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential. |
| Q37357405 | Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats |
| Q34637342 | The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities |
| Q38542451 | Wnt Signaling in Cardiac Disease |
Search more.